Hualv Biology announced that shareholder Jiangsu Gaotou Development Venture Investment Co., Ltd. plans to reduce its shareholding by a total of no more than 6.3154 million shares through centralized bidding trading within 3 months after 15 trading days from the date of announcement, which is not more than 5.36% of the company's latest total share capital.
华绿生物：股东高投发展计划减持不超5.36%公司股份
Hua Lue Biotechnology: Shareholder Gao Tou Development Plan to reduce shareholding by no more than 5.36% of the company's shares
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Hot News
Updated